ClinicalTrials.gov
public full text
Public Domain
The Potential of Oxytocin to Reduce Opioid Abuse Liability and Pain Among Older Adults
Some research suggests that administration of oxytocin with oxycodone may reduce its abuse liability and improve its ability to reduce pain. In a 6-session laboratory study, we will be evaluating the effects of oxycodone and oxytocin (combined and separately, across sessions) on experimentally-induced pain, subjective effects, and decision-making.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy of Spinal Oxytocin in Healthy Volunteers#1163460
- Open-Label Trial Comparing Oxycodone Medications#908220
- OXY-2: The Pharmacogenetics of Oxycodone Analgesia in Human Experimental Pain Models#966736
- The opioid flexion phenotype: postural flexion and nodding in the fentanyl era.#1091386
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3#994775
Record · ID 852523
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive